[1]
2025. Discovering a new nutraceutical based on pollen extract and teupolioside: a prospective monocentric study evaluating its role in alleviating lower urinary tract symptoms in benign prostatic hyperplasia patients. Archivio Italiano di Urologia e Andrologia. 97, 1 (Mar. 2025). DOI:https://doi.org/10.4081/aiua.2025.13412.